Skip to content

Company · founded 2006

Amplyx Pharmaceuticals (United States)

San Diego, United States · amplyx.com

Manage this page

Citations, last 5 years: 395
Works, last 5 years: 12
h-index: 45
Scientists listed: 0
Grants since 2016: 4

Grants received

2017–2019 · research · R44

Developing a novel antifungal targeting Gwt1 for the treatment of invasive aspergillosis and rare mold infections

Karen Joy Shaw · Amplyx Pharmaceuticals (United States) · funded by National Institutes of Health

$725.5kAntifungal resistance and susceptibility

2017–2019 · research · R44

Developing a novel antifungal targeting Gwt1 for the treatment of invasive aspergillosis and rare mold infections

Karen Joy Shaw · Amplyx Pharmaceuticals (United States) · funded by National Institutes of Health

$750.3kAntifungal resistance and susceptibility

2016–2018 · research · R44

Developing a Novel, Fungicidal Therapeutic to Treat Coccidioidomycosis

Karen Joy Shaw · Amplyx Pharmaceuticals (United States) · funded by National Institutes of Health

$728.6kFungal Infections and Studies

2016–2018 · research · R44

Developing a Novel, Fungicidal Therapeutic to Treat Coccidioidomycosis

Karen Joy Shaw · Amplyx Pharmaceuticals (United States) · funded by National Institutes of Health

$732.4kFungal Infections and Studies